Paired organs-should they be treated jointly or separately in internal dosimetry?

PURPOSE Size, shape, and the position of paired organs are different in abdomen. However, the counterpart organs are conventionally treated jointly together in internal dosimetry. This study was performed to quantify the difference of specific absorbed fraction of organs in considering paired organs jointly like single organs or as two separate organs. METHODS Zubal phantom and GATE Monte Carlo package were used to calculate the SAF for the self-absorption and cross-irradiation of the lungs, kidneys, adrenal glands (paired organs), liver, spleen, stomach, and pancreas (single organs). The activity was assumed uniformly distributed in the organs, and simulation was performed for monoenergetic photons of 10, 50, 100, 500, 1000 keV and mono-energetic electrons of 350, 500, 690, 935, 1200 keV. RESULTS The results demonstrated that self-absorption of left and right counterpart organs may be different depending upon the differences in their masses. The cross-irradiations between left-to-right and right-to-left counterpart organs are always equal irrespective of difference in their masses. Cross-irradiation from the left and right counterpart organs to other organs are different (4-24 times in Zubal phantom) depending on the photon energy and organs. The irradiation from a single source organ to the left and right counterpart paired organs is always different irrespective of activity concentration. CONCLUSIONS Left and right counterpart organs always receive different absorbed doses from target organs and deliver different absorbed doses to target organs. Therefore, in application of radiopharmaceuticals in which the dose to the organs plays a role, counterpart organs should be treated separately as two separate organs.© 2011 American Association of Physicists in Medicine.

[1]  Terry Smith,et al.  Comparison of internal radiation doses estimated by MIRD and voxel techniques for a "family" of phantoms , 2000, European Journal of Nuclear Medicine.

[2]  Michael G Stabin,et al.  OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  P B Hoffer,et al.  Computerized three-dimensional segmented human anatomy. , 1994, Medical physics.

[4]  X George Xu,et al.  S-values calculated from a tomographic head/brain model for brain imaging. , 2004, Physics in medicine and biology.

[5]  G. Santin,et al.  GATE: a Geant4-based simulation platform for PET and SPECT integrating movement and time management , 2003 .

[6]  M G Stabin,et al.  MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  D. G. Jones A Realistic Anthrompomorphic Phantom for Calculating Specific Absorbed Fractions of Energy Deposited from Internal Gamma Emitters , 1998 .

[8]  W. S. Snyder,et al.  Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  D. Nosske,et al.  Estimation of patient dose from radiopharmaceuticals using voxel models. , 2005, Cancer biotherapy & radiopharmaceuticals.

[10]  C. E. Clauser,et al.  Weight, volume, and center of mass of segments of the human body , 1969 .

[11]  Lydia Maigne,et al.  Use of the GATE Monte Carlo package for dosimetry applications , 2006 .

[12]  Ignace Lemahieu,et al.  Monte Carlo simulations of a scintillation camera using GATE: validation and application modelling. , 2003, Physics in medicine and biology.

[13]  M G Stabin,et al.  Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Michael G Stabin,et al.  Uncertainties in Internal Dose Calculations for Radiopharmaceuticals , 2008, Journal of Nuclear Medicine.

[15]  J. H. Kim,et al.  Paired-organ and other selected absorbed fraction for the Korean Reference Adult Male model. , 2006, Radiation protection dosimetry.

[16]  Stephen R. Thomas Options for radionuclide therapy: from fixed activity to patient-specific treatment planning. , 2002, Cancer biotherapy & radiopharmaceuticals.

[17]  Ws Snyder,et al.  MIRD Pamphlet #11: S, Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs , 1975 .

[18]  M. Cristy Applying the reciprocal dose principle to heterogeneous phantoms: practical experience from Monte Carlo studies. , 1983, Physics in medicine and biology.

[19]  Jan Seuntjens,et al.  A deformable phantom for 4D radiotherapy verification: design and image registration evaluation. , 2008, Medical physics.

[20]  S. V. N. Santhosh Kumar,et al.  Emphysematous pyelonephritis: A report of three cases , 2007 .

[21]  D Franck,et al.  Dosimetric comparison of Monte Carlo codes (EGS4, MCNP, MCNPX) considering external and internal exposures of the Zubal phantom to electron and photon sources. , 2005, Radiation protection dosimetry.

[22]  B. Wessels,et al.  Patient-specific scaling of reference S-values for cross-organ radionuclide S-values: what is appropriate? , 2007, Radiation protection dosimetry.

[23]  N Petoussi-Henss,et al.  The application of voxel phantoms to the internal dosimetry of radionuclides. , 2003, Radiation protection dosimetry.

[24]  A. Bensman,et al.  Impressive renal damage after acute pyelonephritis in a child , 2010, Pediatric Nephrology.

[25]  X. Xu,et al.  Calculations of specific absorbed fractions of the gastrointestinal tract using a realistic whole body tomographic model. , 2003, Cancer biotherapy & radiopharmaceuticals.

[26]  P. Zanzonico,et al.  Internal radionuclide radiation dosimetry: a review of basic concepts and recent developments. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Sang N. Le,et al.  Non-linear Image-Based Regression of Body Segment Parameters , 2009 .

[28]  D R Fisher Assessments for high dose radionuclide therapy treatment planning. , 2003, Radiation protection dosimetry.